CompuGroup Medical, the healthcare technology specialist, is experiencing significant shifts in its shareholder structure as Goldman Sachs Group has adjusted its position in the company. The investment bank’s total voting rights have decreased from 5.07% to 4.80%, comprising 0.04% direct voting rights and 4.76% through financial instruments. This restructuring includes recovery claims accounting for 2.59% and a combination of call warrants and swap agreements totaling 2.17%. The adjustment comes at a notable time for the Koblenz-based company, as it attracts attention from major market players.
Market Performance and Valuation
The company’s stock has demonstrated remarkable momentum, achieving a 36.21% increase over the past month. Recent trading shows continued positive movement, with shares rising 0.69% to €21.76. The company maintains a market capitalization of €1.2 billion and has announced a dividend of €1.00 for 2024, highlighting its stable market position in the healthcare technology sector. Baader Bank maintains its price target at €72, suggesting significant upside potential for investors.
Ad
CompuGroup Medical Stock: New Analysis – 18 December
Fresh CompuGroup Medical information released. What’s the impact for investors? Our latest independent report examines recent figures and market trends.
Read our updated CompuGroup Medical analysis…
CompuGroup Medical, the healthcare technology specialist, is experiencing significant shifts in its shareholder structure as Goldman Sachs Group has adjusted its position in the company. The investment bank’s total voting rights have decreased from 5.07% to 4.80%, comprising 0.04% direct voting rights and 4.76% through financial instruments. This restructuring includes recovery claims accounting for 2.59% and a combination of call warrants and swap agreements totaling 2.17%. The adjustment comes at a notable time for the Koblenz-based company, as it attracts attention from major market players.
Market Performance and Valuation
The company’s stock has demonstrated remarkable momentum, achieving a 36.21% increase over the past month. Recent trading shows continued positive movement, with shares rising 0.69% to €21.76. The company maintains a market capitalization of €1.2 billion and has announced a dividend of €1.00 for 2024, highlighting its stable market position in the healthcare technology sector. Baader Bank maintains its price target at €72, suggesting significant upside potential for investors.
Ad
Fresh CompuGroup Medical information released. What’s the impact for investors? Our latest independent report examines recent figures and market trends.